The patent at issue in T 1259/22, whilst expiring in August 2024 with SPCs, highlights some of the major challenges for IP strategy in cell therapy
With the New Year around the corner, those in the intellectual property field might be keeping a closer eye on the news than others as 1 January marks Public Domain Day.
Recently, the EPO board of appeal issued a decision in T0056/21 confirming that there is no legal basis for making amendments to the description in order to bring it into line with the allowed set of claims.
The UPC Rules of Procedure (RoP) set out some circumstances when proceedings may be stayed. The first order at the Court of Appeal (UPC_CoA_22/2024) regarding granting of stays has been issued by the UPC.
Following the publication of a Notice from the EPO dated 9 February 2024, a broader range of electronic signatures are now accepted by the EPO, with effect from 1 April 2024.
The UK Court of Appeal has issued its judgement on the UK IPO’s appeal against Emotional Perception AI limited.
The UPC recently rejected a PI application by Ballinno against the Union of European Football Associations for the use of VAR technology at the European Championship in Germany.
The recent decision in T 0209/22 by the EPO Technical Board of Appeal, highlights the different thresholds for novelty and sufficiency in relation to a medical use claim.
In decision T 1437/21, the Board of Appeal held that documents reporting the successful completion of a clinical trial involving the use of a medicine do not render the invention obvious.